 |
市场调查报告书
商品编码
1544612
口腔溃疡治疗市场、机会、成长动力、产业趋势分析与预测，2024-2032Mouth Ulcer Treatment Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
||||||
预计从 2024 年到 2032 年，口腔溃疡治疗市场规模将以 4% 的复合年增长率增长，这得益于口腔健康问题的患病率激增以及对可用治疗方法的认识不断增强。报告显示，全球约有 35 亿人面临口腔健康问题。口腔溃疡是一个普遍存在的问题，影响着相当一部分人群。人们对这些疾病的日益认识，再加上局部应用、口腔冲洗和全身药物等有效治疗方法，推动了市场的扩张。
口腔溃疡治疗的最新进展，包括增强的非处方药解决方案、处方药和替代疗法，不仅提供了更有效的结果，而且满足了更广泛的患者需求。此外，对具有卓越功效、最小化副作用和提高患者依从性的产品的重视将进一步推动市场成长。
整个产业分为药品类别、药品剂型、适应症、配销通路和地区。
根据药物类别，抗组织胺领域的口腔溃疡治疗市场规模预计将在 2024 年至 2032 年间快速增长。透过抑制发炎反应，抗组织胺不仅可以缓解不适，还可以加速口腔溃疡的癒合过程。
就药物剂型而言，喷雾剂领域的口腔溃疡治疗市场预计将在 2024 年至 2032 年间出现强劲增长。口腔喷雾剂可以直接喷洒到受影响的区域，快速有效地将药物输送到最需要的地方。
亚太地区口腔溃疡治疗产业预计从2024 年到2032 年将出现显着成长。是口腔溃疡的已知先兆。此外，印度、中国和东南亚等国家正在见证医疗基础设施的进步，并更加重视医疗保健的可近性，确保更好地提供专业治疗和非处方解决方案。
目录
第 1 章：方法与范围
第 2 章：执行摘要
第 3 章：产业洞察
- 产业生态系统分析
- 产业影响力
- 成长动力
- 口腔溃疡盛行率上升
- 提高认识和诊断
- 治疗方案的进步
- 产业陷阱与挑战
- 严格的监管要求
- 副作用和安全问题
- 成长动力
- 成长潜力分析
- 监管环境
- 技术景观
- 核心技术
- 邻近技术
- 未来市场趋势
- 波特的分析
- PESTEL分析
第 4 章：竞争格局
- 介绍
- 公司市占率分析
- 公司矩阵分析
- 主要市场参与者的竞争分析
- 竞争定位矩阵
- 战略仪表板
第 5 章：市场估计与预测：按药物类别，2021 - 2032 年
- 主要趋势
- 抗菌
- 抗组织胺药
- 止痛药和皮质类固醇
- 其他药物类别
第 6 章：市场估计与预测：按药物剂型，2021 - 2032 年
- 主要趋势
- 喷雾剂
- 漱口水
- 凝胶
- 含片
第 7 章：市场估计与预测：按指标划分，2021 - 2032 年
- 主要趋势
- 口疮性口炎
- 口腔扁平苔癣
- 口腔念珠菌病
- 其他适应症
第 8 章：市场估计与预测：按配销通路划分，2021 - 2032 年
- 主要趋势
- 医院药房
- 零售药局
- 网路药局
第 9 章：市场估计与预测：按地区，2021 - 2032
- 主要趋势
- 北美洲
- 我们
- 加拿大
- 欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
- 中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区
第 10 章：公司简介
- 3M Company
- Blistex Inc.
- Bristol Myers Squibb Company
- Church and Dwight Co., Inc.
- Colgate- Palmolive Company
- Dental Herb Company
- DR. Reddy's Laboratories Limited
- Forward Science
- GSK plc
- Johnson and Johnson
- Patterson Companies, Inc.
- Prestige Consumer Healthcare Inc.
- Pfizer, Inc.
- Prince Care Pharma Pvt Ltd
- Taro Pharmaceutical Industries Ltd.
Mouth ulcer treatment market size is predicted to grow at a 4% CAGR from 2024 to 2032 favored by the surging prevalence of oral health issues and a growing awareness of available treatments. Reports indicate that around 3.5 billion individuals globally grapple with oral health problems. Mouth ulcers, a prevalent concern, affect a notable segment of the population. The increasing acknowledgment of these ailments, combined with effective treatments like topical applications, oral rinses, and systemic medications, fuels the market expansion.
Recent advancements in mouth ulcer treatments, encompassing enhanced over-the-counter solutions, prescription drugs, and alternative therapies, not only provide more effective outcomes but also address a broader spectrum of patient needs. Moreover, the emphasis on products boasting superior efficacy, minimized side effects, and heightened patient adherence will further propel the market growth.
The overall industry is segmented into drug class, drug form, indication, distribution channel, and region.
Based on drug class, the mouth ulcer treatment market size from the antihistamine segment is poised to grow rapidly from 2024 to 2032. This surge is attributed to the proven efficacy of antihistamines in mitigating symptoms tied to allergic reactions and inflammation. By dampening the inflammatory response, antihistamines not only alleviate discomfort but also expedite the healing process of mouth ulcers.
In terms of drug form, the mouth ulcer treatment market from the sprays segment is expected to witness robust growth between 2024 and 2032. This owing to their convenience, ease of application, and targeted relief. Oral sprays provide direct application to the affected area, delivering medication quickly and effectively where it is needed most.
Asia Pacific mouth ulcer treatment industry is set to experience a notable growth rate from 2024 to 2032. Lifestyle shifts, notably a rise in processed food consumption and a dip in essential nutrient intake heighten the risk of nutritional deficiencies, a known precursor to mouth ulcers. Furthermore, nations like India, China, and in Southeast Asia are witnessing advancements in medical infrastructure and a heightened emphasis on healthcare access, ensuring better availability of specialized treatments and over-the-counter solutions.
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising prevalence of mouth ulcers
- 3.2.1.2 Increasing awareness and diagnosis
- 3.2.1.3 Advancements in treatment options
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Stringent regulatory requirements
- 3.2.2.2 Side effects and safety concerns
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.5.1 Core technologies
- 3.5.2 Adjacent technologies
- 3.6 Future market trends
- 3.7 Porter's analysis
- 3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Antimicrobial
- 5.3 Antihistamine
- 5.4 Analgesics and corticosteroids
- 5.5 Other drug classes
Chapter 6 Market Estimates and Forecast, By Drug Form, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Sprays
- 6.3 Mouthwash
- 6.4 Gels
- 6.5 Lozenges
Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Aphthous stomatitis
- 7.3 Oral lichen planus
- 7.4 Oral candidiasis
- 7.5 Other indications
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
- 8.1 Key trends
- 8.2 Hospital pharmacies
- 8.3 Retail pharmacies
- 8.4 Online pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 9.1 Key trends
- 9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
- 9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
- 9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
- 9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
- 9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
- 10.1 3M Company
- 10.2 Blistex Inc.
- 10.3 Bristol Myers Squibb Company
- 10.4 Church and Dwight Co., Inc.
- 10.5 Colgate- Palmolive Company
- 10.6 Dental Herb Company
- 10.7 DR. Reddy's Laboratories Limited
- 10.8 Forward Science
- 10.9 GSK plc
- 10.10 Johnson and Johnson
- 10.11 Patterson Companies, Inc.
- 10.12 Prestige Consumer Healthcare Inc.
- 10.13 Pfizer, Inc.
- 10.14 Prince Care Pharma Pvt Ltd
- 10.15 Taro Pharmaceutical Industries Ltd.
